DiaSorin SpA
MIL:DIA
Relative Value
The Relative Value of one DIA stock under the Base Case scenario is 110.81 EUR. Compared to the current market price of 102.6 EUR, DiaSorin SpA is Undervalued by 7%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
DIA Competitors Multiples
DiaSorin SpA Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
IT |
DiaSorin SpA
MIL:DIA
|
5.5B EUR | 4.8 | 34.2 | 16.4 | 25.9 | ||
US |
Abbott Laboratories
NYSE:ABT
|
182.3B USD | 4.5 | 32.4 | 19.1 | 28.5 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.1B USD | 18.5 | 68 | 55.8 | 69.9 | ||
US |
Stryker Corp
NYSE:SYK
|
123.6B USD | 5.9 | 36.8 | 23.9 | 29.4 | ||
IE |
Medtronic PLC
NYSE:MDT
|
111.1B USD | 3.4 | 26.4 | 14 | 19.8 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
107B USD | 7.3 | 60.6 | 30.5 | 45.1 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.5B USD | 3.5 | 56.2 | 18.8 | 39.7 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.8B EUR | 2.7 | 38.8 | 18.6 | 31.3 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
374.7B CNY | 10.4 | 30.8 | 28.3 | 28.3 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51B USD | 8.3 | 36.1 | 26.2 | 28.3 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
49.5B USD | 13 | 77.4 | 57.9 | 75.3 |